...
首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Clinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus
【24h】

Clinical application of CardioSEAL/STARFlex devices for transcatheter closure of atrial septal defect, patent foramen ovale and patent ductus arteriosus

机译:CardioSEAL / STARFlex装置在经导管封闭房间隔缺损,卵圆孔未闭和动脉导管未闭的临床应用

获取原文
           

摘要

CardioSEAL/STARFlex devices (CS/SF) are double umbrella systems, which have several technical advantages such as: low profile, low nitinol content and relatively large covering surface. Our clinical experience with application of those devices is presented. Material and methods: From 1999 till 2005 transcatheter closure of undesirable shunts with CS/SF was performed in 45 patients (pts). They were divided into 3 groups: – Atrial Septal Defect (ASD): 32 pts aged 12.3 (4 to 27) years; – Persistent Foramen Ovale (PFO): 10 pts aged 31.7 (13 to 54) years; – Patent Ductus Arteriosus (PDA): 3 pts aged 16, 17 and 62 years. Indications for CS/SF implantations were: – in ASD: small, centrally located defect or multifenestrated aneurysm of the interatrial septum (IAS); – in PFO: history of cryptogenic transient ischemic attacks or stroke and right to left shunt through short PFO tunnel ( Results: In all but 2 pts the procedures were completed successfully. The reason of 2 procedural failures during ASD closure was unsatisfactory umbrella position. Complete closure of undesirable communications was achieved in all but one pt with multiperforated aneurysm of IAS. In the latter pt the residual shunt was of no haemodynamic significance. Conclusions: Transcatheter closure of some ASD, PDA and PFO with Cardioseal/Staflex umbrella can be the treatment of choice in a selected group of patients.
机译:CardioSEAL / STARFlex设备(CS / SF)是双重保护伞系统,具有多种技术优势,例如:薄型,镍钛合金含量低和覆盖面积较大。介绍了我们使用这些设备的临床经验。材料和方法:从1999年至2005年,对45例患者进行了经导管封闭的CS / SF不良分流术。他们分为3组:–房间隔缺损(ASD):32分,年龄为12.3(4至27)岁; –永久性卵圆孔(PFO):10分,年龄31.7(13至54)岁; –动脉导管未闭(PDA):3位分别为16、17和62岁的患者。 CS / SF植入的适应症为:–在ASD中:房间隔小(IAS)中央位置的小缺陷或多窗动脉瘤; –在PFO中:短暂的PFO隧道发生了隐源性短暂性脑缺血发作或中风和从右向左分流的历史(结果:除2分外,所有过程均已成功完成。ASD闭合期间2例程序失败的原因是伞位不理想。完成IAS的多孔动脉瘤除1 pt外,其余所有患者均实现了不良通信的闭合,在后者中,残余分流不具有血流动力学意义结论:可以通过心脏瓣膜/ Staflex伞经导管闭合部分ASD,PDA和PFO进行治疗在选定的一组患者中选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号